...
首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Breast Cancer Molecular Subtypes and Oxidative DNA Damage
【24h】

Breast Cancer Molecular Subtypes and Oxidative DNA Damage

机译:乳腺癌分子亚型和氧化性DNA损伤

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Oxidative stress is thought to play a major role in etiology of many cancers, including breast cancer. 8-hydroxy-2'deoxyguanosine (8-OHdG) is the most abundant marker of oxidative DNA damage. The aim of this study was to assess the extent of oxidative DNA damage in different breast cancer molecular surrogate subtypes to investigate the prognostic relevance and role of oxidative base lesion (8-OHdG) in the etiology of breast cancer. Materials and Methods: 8-OHdG expression was im-munohistochemicaly studied on tissue microarrays constructed from 152 patients with invasive breast cancer. Expression was correlated with other prognostic factors, as well as different breast cancer molecular surrogate subtypes such as luminal A, luminal B [human epidermal growth factor receptor 2 (HER2) negative], luminal B (HER2 positive), HER2-enriched ad triple-negative tumors. Results: Triple-negative breast carcinomas (TNBCs) were more frequently 8-OHdG negative compared with non-TNBCs (P = 0.036). There was no statistically significant difference between 8-OHdG expression and other breast cancer molecular subtypes. In univariate analysis, there was no significant difference between 8-OHdG expression and breast cancer-specific death, although in multivariate analysis 8-OHdG over-expression was associated with better breast cancer-specific survival (BCSS) (odds ratio = 0.04, 95% confidence interval, 0.002-0.62). In Cox regression analysis, patients with moderate and strong 8-OHdG expression had 0.9 times smaller breast cancer death hazard ratio than patients with negative 8-OHdG expression. Conclusions: Oxidative stress may have less impact in the pathogenesis of TNBCs compared with other surrogate breast cancer molecular subtypes. 8-OHdG may be a promising bio-marker in the prediction of prognosis for breast cancer patients.
机译:背景:氧化应激被认为在包括乳腺癌在内的许多癌症的病因中起主要作用。 8-羟基-2'脱氧鸟苷(8-OHdG)是氧化DNA损伤最丰富的标记。这项研究的目的是评估不同的乳腺癌分子替代亚型中氧化性DNA损伤的程度,以研究氧化性基础病变(8-OHdG)在乳腺癌病因中的预后相关性和作用。材料与方法:在152例浸润性乳腺癌患者的组织芯片上进行了免疫组织化学研究了8-OHdG的表达。表达与其他预后因素以及不同的乳腺癌分子替代亚型相关,例如腔A,腔B [人表皮生长因子受体2(HER2)阴性],腔B(HER2阳性),富含HER2的ad三联体阴性肿瘤。结果:与非TNBC相比,三阴性乳腺癌(TNBC)更常见于8-OHdG阴性(P = 0.036)。 8-OHdG表达与其他乳腺癌分子亚型之间无统计学差异。在单变量分析中,8-OHdG表达与乳腺癌特异性死亡之间无显着差异,尽管在多变量分析中,8-OHdG过表达与更好的乳腺癌特异性生存率(BCSS)相关(比值= 0.04,95 %置信区间,0.002-0.62)。在Cox回归分析中,中度和强度8-OHdG表达患者的乳腺癌死亡危险比是8-OHdG阴性患者的0.9倍。结论:与其他替代乳腺癌分子亚型相比,氧化应激可能对TNBCs的发病机制影响较小。 8-OHdG可能是预测乳腺癌患者预后的有前途的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号